Table 9 Discretization of continuous features.
Risk Classes | 0 | 1 | 2 | 3 | 4 | NaN for each feature |
---|---|---|---|---|---|---|
Age (years) | 18–27 | 28–32 | 33–37 | 38–42 | >42 | 14 |
APCR (%) | 2.4–3.5 | 1.84–2.39 & 3.51–4.05 | 1.28–1.83 & 4.06–4.61 | 0.16–1.27 & 4.62–5.73 | <0.16 & ≥ 5.74 | 393 |
Protein C (%) | 70–130 | 55–69.99 & 130.01–144.99 | 40–54.99 & 145–159.99 | 25–39.99 & 160–175 | <25 & ≥ 175 | 271 |
Protein S (%) | 53–109 | 38–52.99 & 109.01–123.99 | 23–37.99 & 124–138.99 | 8–22.99 & 139–154 | <8 & ≥ 154 | 263 |
AT III (%) | 80–120 | 65–79.99 & 120.01–134.99 | 50–64.99 & 135–149.99 | 35–49.99 & 150–165 | <35 & ≥ 165 | 364 |
Omocysteinemia (µM) | 5–12 | 4–4.99 & 12.01–14.99 | 3–3.99 & 15–17.99 | 2–2.99 & 18–21 | <2 & ≥ 21 | 272 |
TSH (mU/ml) | 0.5–3.8 | 0.4–0.49 & 3.81–4.79 | 0.3–0.39 & 4.8–7.79 | 0.1–0.29 & 7.8–17.99 | <0.1 & ≥ 18 | 200 |
BMI (Kg/m2) | 18.5–24.99 | 16.5–18.49 | <16.5 | 25–30 | >30 | 143 |